MoneyWorks4Me

Cipla reports 7% rise in Q3 consolidated net profit

25 Jan 2023 Evaluate

Cipla has reported results for third quarter ended December 31, 2022 (Q3FY23).

The company has reported a fall of 7.16% in its net profit at Rs 678.52 crore for the quarter under review as compared to Rs 730.83 crore for the same quarter in the previous year. However, total income of the company increased 1.77% at Rs 4,026.57 crore for Q3FY23 as compared to Rs 3,956.60 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 6.73% in its net profit at Rs 807.83 crore for the quarter under review as compared to Rs 756.88 crore for the same quarter in the previous year. Total income of the company increased 6.36% at Rs 5,924.53 crore for Q3FY23 as compared to Rs 5,570.15 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..